Pfizer Inc. stock outperforms market despite losses on the day
Shares of Pfizer Inc. PFE, -0.65% slid 0.65% to $50.80 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX, -1.20% falling 1.20% to 3,783.22…
From the Equity Insider archive. This article dates from Dec 28, 2022 and is preserved as first published.
Shares of Pfizer Inc. PFE, -0.65% slid 0.65% to $50.80 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX, -1.20% falling 1.20% to 3,783.22 and Dow Jones Industrial Average DJIA, -1.10% falling 1.10% to 32,875.71. This was the stock’s second consecutive day of losses. Pfizer Inc. closed $9.00 short of its 52-week high ($59.80), which the company achieved on December 31st.
80 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX, -1.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson JNJ, -0.43% fell 0.43% to $176.66, Eli Lilly & Co. LLY, +0.09% rose 0.09% to $365.22, and Abbott Laboratories ABT, -0.68% fell 0.68% to $107.83. Trading volume (10.0 M) remained 11.4 million below its 50-day average volume of 21.4 M.
